| Code | CSB-MP011673HU(A4) |
| Abbreviation | Recombinant Human CXCR2 protein-VLPs (Active) |
| MSDS | |
| Size | $558 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CXCR2 mediates neutrophil recruitment and tumor-associated inflammation, making it a target of interest in cancer immunology and metastasis research. This full-length receptor (aa 1–360) is presented in virus-like particles produced in mammalian cells, a format that preserves native membrane topology and post-translational modifications critical for conformational epitope display. Functional ELISA demonstrates specific antibody binding with an EC50 of 0.37–0.47 ng/mL, confirming that the receptor retains its native structure and supports use in therapeutic antibody epitope mapping, competitive inhibition screening, and blocking antibody validation assays. With endotoxin levels below 1.0 EU/μg, this VLP-displayed CXCR2 meets the quality thresholds commonly required for ligand-binding studies, SPR or BLI affinity characterization, and small-molecule inhibitor screening campaigns targeting chemokine receptor signaling in oncology.
There are currently no reviews for this product.